Clinical Trials Browser

Phase 1 × Not yet recruiting × ivarmacitinib × Clear all

NCT05900089 2023-06-12

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Phase 1 Not yet recruiting

Lymphoma, T-Cell, Peripheral